Skip to main content
Journal cover image

Alefacept (LFA3-Ig), portal venous donor specific transfusion (PVDST), and sirolimus prolong renal allograft survival in non-human primates

Publication ,  Conference
Dhanireddy, KK; Bruno, DA; Zhang, X; Leopardi, FV; Johnson, LB; Kirk, AD
Published in: Journal of the American College of Surgeons
September 2006

Duke Scholars

Published In

Journal of the American College of Surgeons

DOI

ISSN

1072-7515

Publication Date

September 2006

Volume

203

Issue

3

Start / End Page

S92 / S92

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Surgery
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dhanireddy, K. K., Bruno, D. A., Zhang, X., Leopardi, F. V., Johnson, L. B., & Kirk, A. D. (2006). Alefacept (LFA3-Ig), portal venous donor specific transfusion (PVDST), and sirolimus prolong renal allograft survival in non-human primates. In Journal of the American College of Surgeons (Vol. 203, pp. S92–S92). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/j.jamcollsurg.2006.05.240
Dhanireddy, Kiran K., David A. Bruno, Xiaojie Zhang, Frank V. Leopardi, Lynt B. Johnson, and Allan D. Kirk. “Alefacept (LFA3-Ig), portal venous donor specific transfusion (PVDST), and sirolimus prolong renal allograft survival in non-human primates.” In Journal of the American College of Surgeons, 203:S92–S92. Ovid Technologies (Wolters Kluwer Health), 2006. https://doi.org/10.1016/j.jamcollsurg.2006.05.240.
Dhanireddy KK, Bruno DA, Zhang X, Leopardi FV, Johnson LB, Kirk AD. Alefacept (LFA3-Ig), portal venous donor specific transfusion (PVDST), and sirolimus prolong renal allograft survival in non-human primates. In: Journal of the American College of Surgeons. Ovid Technologies (Wolters Kluwer Health); 2006. p. S92–S92.
Dhanireddy, Kiran K., et al. “Alefacept (LFA3-Ig), portal venous donor specific transfusion (PVDST), and sirolimus prolong renal allograft survival in non-human primates.” Journal of the American College of Surgeons, vol. 203, no. 3, Ovid Technologies (Wolters Kluwer Health), 2006, pp. S92–S92. Crossref, doi:10.1016/j.jamcollsurg.2006.05.240.
Dhanireddy KK, Bruno DA, Zhang X, Leopardi FV, Johnson LB, Kirk AD. Alefacept (LFA3-Ig), portal venous donor specific transfusion (PVDST), and sirolimus prolong renal allograft survival in non-human primates. Journal of the American College of Surgeons. Ovid Technologies (Wolters Kluwer Health); 2006. p. S92–S92.
Journal cover image

Published In

Journal of the American College of Surgeons

DOI

ISSN

1072-7515

Publication Date

September 2006

Volume

203

Issue

3

Start / End Page

S92 / S92

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Surgery
  • 3202 Clinical sciences
  • 1103 Clinical Sciences